Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 21 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

The mission of ETHA is to give the thrombosis and hemostasis community a voice and drive prioritisation of thrombosis and hemostasis in the EU patient safety and research programs. With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.

To learn more about ETHA’s initial area of priority, read the consensus statement, here.

News

Saving Lives of Cancer Patients by Addressing Cancer-Associa...

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...

Continue reading

European Commission Relevant Calls for Proposals

Looking for funding opportunities? The following may be relevant to your science and research interests in the field of bleeding and clotting. For each one, you will find more information and the procedures to follow by clicking on ...

Continue reading
Events
World Thrombosis Day
13 October

World Thrombosis Day (WTD) focuses attention on the often overlooked and misunderstood condition of thrombosis.

More events